Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 184 of the 185 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Neurotrophins are important regulators of neuronal and non-neuronal functions. As such, the neurotrophins and their receptors, the tropomyosin receptor kinase (Trk) family of receptor tyrosine kinases, has attracted intense research interest and their role in multiple diseases including Alzheimer’s disease has been described. Attempts to administer neurotrophins to patients have been reported, but the clinical trials have so far have been hampered by side effects or a lack of clear efficacy. Thus, much of the focus during recent years has been on identifying small molecules acting as agonists or positive allosteric modulators (PAMs) of Trk receptors. Two examples of successful discovery and development of PAMs are the TrkA-PAM E2511 and the pan-Trk PAM ACD856. E2511 has been reported to have disease-modifying effects in preclinical models, whereas ACD856 demonstrates both a symptomatic and a disease-modifying effect in preclinical models. Both molecules have reached the stage of clinical development and were reported to be safe and well tolerated in clinical phase 1 studies, albeit with different pharmacokinetic profiles. These two emerging small molecules are interesting examples of possible novel symptomatic and disease-modifying treatments that could complement the existing anti-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease. This review aims to present the concept of positive allosteric modulators of the Trk receptors as a novel future treatment option for Alzheimer’s disease and other neurodegenerative and cognitive disorders, and the current preclinical and clinical data supporting this new concept. Preclinical data indicate dual mechanisms, not only as cognitive enhancers, but also a tentative neurorestorative function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 (a) A schematic representation of Trk receptor expression summarized from [21,24,25,26,27] and the Human Protein Atlas initiative (https://www.proteinatlas.org, accessed on 16 June 2024) where red indicates high levels and blue indicates low levels of expression. Figures (b,c) are RNAseq data from Allen Brain Map, Allen Institute for Brain Science; Human multiple cortical areas—SMART-seq (https://celltypes.brain-map.org/rnaseq, accessed on 16 June 2024). (b) This data set includes single-nucleus transcriptomes from 49,495 nuclei across multiple human cortical areas. Individual layers of cortex were dissected from tissues covering the middle temporal gyrus. (c) The data set includes single-cell transcriptomes from 76,533 total cells derived from two post-mortem human brain specimens in the primary motor cortex.](https://figures.cochat.ai/paper-figures/749de766437f49e999410a99fe443e04/positive-allosteric-modulators-of-trk-receptors-for-the-treatment-of-alzheimers-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Preclinical studies identify TrkB positive allosteric modulators as stabilizers of induced plasticity, converting transient synaptic change into a more durable circuit state [114,115].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [115]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lecanemab in early Alzheimer's disease
van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678
Greene, L. A., & Tischler, A. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2424 · Cited by 5,553
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 3×
“These pathways are activated upon ligand binding and autophosphorylation of tyrosine (Y) 674/675 that governs the catalytic activity of the kinase activity.”
BackgroundPurification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822 · cited 2×
“…tumor necrosis factor receptor superfamily [19]. from NGF, the mammalian family of neurotrophins includes brain-derived neurotrophic factor (BDNF) [9,10], NT-3 [11,12], and NT4/5 [13–15], which bind to the cognate tropomyosin receptor kinase (Trk) family of receptor tyrosine kinases, including…”
BackgroundDonanemab in Early Alzheimer’s Disease
Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100708 · Cited by 1,728 · cited 2×
“Secreted pro-neurotrophins are processed by extracellular matrix proteases to produce the mature forms in a regulated cascade-like manner, as exemplified for pro-NGF [80].”
BackgroundRegulation of Cell Survival by Secreted Proneurotrophins
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670
NTRK fusion-positive cancers and TRK inhibitor therapy
Cocco, E., Scaltriti, M., & Drilon, A. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0113-0 · Cited by 1,485
The trk proto-oncogene encodes a receptor for nerve growth factor
Klein, R., Jing, S., Nanduri, V., O'Rourke, E., & Barbacid, M. (1991) · Cell · doi:10.1016/0092-8674(91)90419-y · Cited by 1,401
Huang, Z. J., Kirkwood, A., Pizzorusso, T., Porciatti, V., Morales, B., Bear, M. F., Maffei, L., & Tonegawa, S. (1999) · Cell · doi:10.1016/s0092-8674(00)81509-3 · Cited by 1,198
Hohn, A., Leibrock, J., Bailey, K., & Barde, Y.-A. (1990) · Nature · doi:10.1038/344339a0 · Cited by 1,145 · cited 2×
“Apart Apart from NGF, the mammalian family of neurotrophins includes brain-derived neurotrophic factor (BDNF) [9,10], NT-3 [11,12], and NT4/5 [13–15], which bind to the cognate tropomyosin receptor kinase (Trk) family of receptor tyrosine kinases, including TrkA [16], TrkB [17], and TrkC [18] as…”
BackgroundCrowley, C., Spencer, S. D., Nishimura, M. C., Chen, K. S., Pitts-Meek, S., Armaninl, M. P., Ling, L. H., McMahon, S. B., Shelton, D. L., Levinson, A. D., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90378-6 · Cited by 1,069
Mice lacking brain-derived neurotrophic factor develop with sensory deficits
Ernfors, P., Lee, K.-F., & Jaenisch, R. (1994) · Nature · doi:10.1038/368147a0 · Cited by 1,067 · cited 3×
“Interest-ingly, one ongoing clinical trial with adeno-associated virus (AAV) delivery of BDNF into the brain will address the effects on delivery of BDNF on neurodegeneration in patients with mild cognitive impairment (MCI) or early AD (NCT05040217).”
BackgroundTrkB signalling pathways in LTP and learning
Minichiello, L. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2738 · Cited by 1,055 · cited 1×
“Interest-ingly, one ongoing clinical trial with adeno-associated virus (AAV) delivery of BDNF into the brain will address the effects on delivery of BDNF on neurodegeneration in patients with mild cognitive impairment (MCI) or early AD (NCT05040217).”
BackgroundA phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., et al. (2005) · Nature Medicine · doi:10.1038/nm1239 · Cited by 1,050 · cited 2×
“Although much of the focus on allosteric regulation of RTKs, and especially on Trk receptors, has been on identifying negative allosteric modulators or allosteric inhibitors of TrkA [134–136], there are now recent reports of positive allosteric modulators of Trk receptors [137,138].”
BackgroundHariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06690.2003 · Cited by 1,045 · cited 2×
“For instance, the site of interaction for Src homology domain containing 1 (SHC1) protein on the TrkA receptor is at phospho(p)-Y490, the site for phosphatidylinositol kinase 3 (PI3K) is at pY751, and the site for phospholipase C gamma (PLC γ ) is at pY785 (Figure 3).”
BackgroundSevere sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene
Smeyne, R. J., Klein, R., Schnapp, A., Long, L. K., Bryant, S., Lewin, A., Lira, S. A., & Barbacid, M. (1994) · Nature · doi:10.1038/368246a0 · Cited by 981
Klein, R., Nanduri, V., Jing, S., Lamballe, F., Tapley, P., Bryant, S., Cordon-Cardo, C., Jones, K. R., Reichardt, L. F., & Barbacid, M. (1991) · Cell · doi:10.1016/0092-8674(91)90628-c · Cited by 958 · cited 2×
“…and NT4/5 [13–15], which bind to the cognate tropomyosin receptor kinase (Trk) family of receptor tyrosine kinases, including TrkA [16], TrkB [17], and TrkC [18] as well as to a common receptor p75NTR, belonging to the tumor necrosis factor receptor superfamily [19]. from NGF, the mammalian…”
BackgroundNeurotrophin-5: A novel neurotrophic factor that activates trk and trkB
Berkemeier, L. R., Winslow, J. W., Kaplan, D. R., Nikolics, K., Goeddel, D. V., & Rosenthal, A. (1991) · Neuron · doi:10.1016/0896-6273(91)90287-a · Cited by 836
Hallböök, F., Ibáñez, C. F., & Persson, H. (1991) · Neuron · doi:10.1016/0896-6273(91)90180-8 · Cited by 834
Rios, M., Fan, G., Fekete, C., Kelly, J., Bates, B., Kuehn, R., Lechan, R. M., & Jaenisch, R. (2001) · Molecular Endocrinology · doi:10.1210/me.15.10.1748 · Cited by 780
Ernfors, P., Ibáñez, C. F., Ebendal, T., Olson, L., & Persson, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5454 · Cited by 700 · cited 2×
“Apart Apart from NGF, the mammalian family of neurotrophins includes brain-derived neurotrophic factor (BDNF) [9,10], NT-3 [11,12], and NT4/5 [13–15], which bind to the cognate tropomyosin receptor kinase (Trk) family of receptor tyrosine kinases, including TrkA [16], TrkB [17], and TrkC [18] as…”
BackgroundKlein, R., Smeyne, R. J., Wurst, W., Long, L. K., Auerbach, B. A., Joyner, A. L., & Barbacid, M. (1993) · Cell · doi:10.1016/0092-8674(93)90683-h · Cited by 699
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Jang, S.-W., Liu, X., Yepes, M., Shepherd, K. R., Miller, G. W., Liu, Y., Wilson, W. D., Xiao, G., Blanchi, B., Sun, Y. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913572107 · Cited by 686
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.034 · Cited by 663
Ip, N. Y., Ibáñez, C. F., Nye, S. H., McClain, J., Jones, P. F., Gies, D. R., Belluscio, L., Le Beau, M. M., Espinosa, R., & Squinto, S. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3060 · Cited by 626 · cited 2×
“Apart Apart from NGF, the mammalian family of neurotrophins includes brain-derived neurotrophic factor (BDNF) [9,10], NT-3 [11,12], and NT4/5 [13–15], which bind to the cognate tropomyosin receptor kinase (Trk) family of receptor tyrosine kinases, including TrkA [16], TrkB [17], and TrkC [18] as…”
BackgroundKlein, R., Silos-Santiago, I., Smeyne, R. J., Lira, S. A., Brambilla, R., Bryant, S., Zhang, L., Snider, W. D., & Barbacid, M. (1994) · Nature · doi:10.1038/368249a0 · Cited by 624
A de novo mutation affecting human TrkB associated with severe obesity and developmental delay
Yeo, G. S. H., Connie Hung, C.-C., Rochford, J., Keogh, J., Gray, J., Sivaramakrishnan, S., O'Rahilly, S., & Farooqi, I. S. (2004) · Nature Neuroscience · doi:10.1038/nn1336 · Cited by 607
BDNF signaling in context: From synaptic regulation to psychiatric disorders
Wang, C. S., Kavalali, E. T., & Monteggia, L. M. (2022) · Cell · doi:10.1016/j.cell.2021.12.003 · Cited by 607
Stephens, R. M., Loeb, D. M., Copeland, T. D., Pawson, T., Greene, L. A., & Kaplan, D. R. (1994) · Neuron · doi:10.1016/0896-6273(94)90223-2 · Cited by 541
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504 · cited 2×
“Thus, efforts to identify novel therapeutics targeting the Intracellular processing of pro-neurotrophins is dependent on endoproteases such as protease convertases (PC), including furin and PCs neurotrophin pathways are warranted [83].”
BackgroundHuman β-nerve growth factor gene sequence highly homologous to that of mouse
Ullrich, A., Gray, A., Berman, C., & Dull, T. J. (1983) · Nature · doi:10.1038/303821a0 · Cited by 480
Chao, M. V. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251106 · Cited by 479
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Moliner, R., Girych, M., Brunello, C. A., Kovaleva, V., Biojone, C., Enkavi, G., Antenucci, L., Kot, E. F., Goncharuk, S. A., Kaurinkoski, K., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01316-5 · Cited by 478 · cited 2×
“Both E2511 and ACD856 have been described as having no or very low agonistic effect on receptor function, but rather exert their action by modulating signaling [137,138,143,144].”
BackgroundIntracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease
Eriksdotter Jönhagen, M., Nordberg, A., Amberla, K., Bäckman, L., Ebendal, T., Meyerson, B., Olson, L., Seiger, Å., Shigeta, M., Theodorsson, E., et al. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017069 · Cited by 472
Learning deficit in BDNF mutant mice.
Linnarsson, S., Björklund, A., & Ernfors, P. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01687.x · Cited by 471
Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor
Scott, J., Selby, M., Urdea, M., Quiroga, M., Bell, G. I., & Rutter, W. J. (1983) · Nature · doi:10.1038/302538a0 · Cited by 466
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III) (1999) · Neurology · doi:10.1212/wnl.52.7.1427 · Cited by 451
The Role of BDNF on Neural Plasticity in Depression
Yang, T., Nie, Z., Shu, H., Kuang, Y., Chen, X., Cheng, J., Yu, S., & Liu, H. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00082 · Cited by 435
Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma.
Bonini, S., Lambiase, A., Bonini, S., Angelucci, F., Magrini, L., Manni, L., & Aloe, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10955 · Cited by 427
Molecular cloning of a human gene that is a member of the nerve growth factor family.
Jones, K. R., & Reichardt, L. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.20.8060 · Cited by 404
Nandi, A., Counts, N., Chen, S., Seligman, B., Tortorice, D., Vigo, D., & Bloom, D. E. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101580 · Cited by 402 · cited 1×
“Secreted pro-neurotrophins are processed by extracellular matrix proteases to produce the mature forms in a regulated cascade-like manner, as exemplified for pro-NGF [80].”
BackgroundBruno, M. A., & Cuello, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510645103 · Cited by 344
Mechanisms, locations, and kinetics of synaptic BDNF secretion: An update
Leßmann, V., & Brigadski, T. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.06.004 · Cited by 337
Bonnington, J. K., & McNaughton, P. A. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.039990 · Cited by 336
Brain-derived neurotrophic factor in Huntington disease
Ferrer, I., Goutan, E., Marı́n, C., Rey, M. J., & Ribalta, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02237-x · Cited by 331
Sobreviela, T., Clary, D. O., Reichardt, L. F., Brandabur, M. M., Kordower, J. H., & Mufson, E. J. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903500407 · Cited by 325
Stage-dependent BDNF serum concentrations in Alzheimer’s disease
Laske, C., Stransky, E., Leyhe, T., Eschweiler, G. W., Wittorf, A., Richartz, E., Bartels, M., Buchkremer, G., & Schott, K. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0397-y · Cited by 324
NGF and Its Receptors in the Regulation of Inflammatory Response
Minnone, G., De Benedetti, F., & Bracci-Laudiero, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051028 · Cited by 321
McDade, E., Cummings, J. L., Dhadda, S., Swanson, C. J., Reyderman, L., Kanekiyo, M., Koyama, A., Irizarry, M., Kramer, L. D., & Bateman, R. J. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01124-2 · Cited by 303
Erickson, J. T., Conover, J. C., Borday, V., Champagnat, J., Barbacid, M., Yancopoulos, G., & Katz, D. M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-17-05361.1996 · Cited by 292
Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases
SEIDAH, N. G., BENJANNET, S., PAREEK, S., SAVARIA, D., HAMELIN, J., GOULET, B., LALIBERTÉ, J., LAZURE, C., CHRÉTIEN, M., & MURPHY, R. A. (1996) · Biochemical Journal · doi:10.1042/bj3140951 · Cited by 291
Obermeier, A., Lammers, R., Wiesmüller, K. H., Jung, G., Schlessinger, J., & Ullrich, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49410-6 · Cited by 290
EFFECTS OF MOUSE TUMOR TRANSPLANTATION ON THE NERVOUS SYSTEM
Levi‐Montalcini, R. (1952) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1952.tb26548.x · Cited by 269
Neurotrophins and the immune system
Vega, J. A., García‐Suárez, O., Hannestad, J., Pérez‐Pérez, M., & Germanà, A. (2003) · Journal of Anatomy · doi:10.1046/j.1469-7580.2003.00203.x · Cited by 268
Neurotrophin signalling: novel insights into mechanisms and pathophysiology
Mitre, M., Mariga, A., & Chao, M. V. (2017) · Clinical Science · doi:10.1042/cs20160044 · Cited by 263
Self-amplifying autocrine actions of BDNF in axon development
Cheng, P.-L., Song, A.-H., Wong, Y.-H., Wang, S., Zhang, X., & Poo, M.-M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115907108 · Cited by 250
Nerve Growth Factor Signaling and Its Contribution to Pain
Barker, P. A., Mantyh, P., Arendt-Nielsen, L., Viktrup, L., & Tive, L. (2020) · Journal of Pain Research · doi:10.2147/jpr.s247472 · Cited by 250
Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain
Lärkfors, L., Ebendal, T., Whittemore, S. R., Persson, H., Hoffer, B., & Olson, L. (1987) · Molecular Brain Research · doi:10.1016/0169-328x(87)90044-1 · Cited by 245
Ruit, K. G., Elliott, J. L., Osborne, P. A., Yan, Q., & Snider, W. D. (1992) · Neuron · doi:10.1016/0896-6273(92)90284-k · Cited by 241
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease
Rafii, M. S., Baumann, T. L., Bakay, R. A. E., Ostrove, J. M., Siffert, J., Fleisher, A. S., Herzog, C. D., Barba, D., Pay, M., Salmon, D. P., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.09.004 · Cited by 223
Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid
Laudiero, L. B., Aloe, L., Levi-Montalcini, R., Buttinelli, C., Schilter, D., Gillessen, S., & Otten, U. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90762-v · Cited by 220
Rafii, M. S., Tuszynski, M. H., Thomas, R. G., Barba, D., Brewer, J. B., Rissman, R. A., Siffert, J., Aisen, P. S., & for the AAV2-NGF Study Team (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0233 · Cited by 219
Hong, C.-J., Huo, S.-J., Yen, F.-C., Tung, C.-L., Pan, G.-M., & Tsai, S.-J. (2003) · Neuropsychobiology · doi:10.1159/000074636 · Cited by 218
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
Westphalen, C. B., Krebs, M. G., Le Tourneau, C., Sokol, E. S., Maund, S. L., Wilson, T. R., Jin, D. X., Newberg, J. Y., Fabrizio, D., Veronese, L., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00206-y · Cited by 207
TrkA, But Not TrkC, Receptors Are Essential for Survival of Sympathetic NeuronsIn Vivo
Fagan, A. M., Zhang, H., Landis, S., Smeyne, R. J., Silos-Santiago, I., & Barbacid, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06208.1996 · Cited by 205
NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis
Shimazu, K., Zhao, M., Sakata, K., Akbarian, S., Bates, B., Jaenisch, R., & Lu, B. (2006) · Learning & Memory · doi:10.1101/lm.76006 · Cited by 200
Neurotrophins and Neuropathic Pain: Role in Pathobiology
Khan, N., & Smith, M. (2015) · Molecules · doi:10.3390/molecules200610657 · Cited by 200
NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients
Sahenk, Z., Nagaraja, H. N., McCracken, B. S., King, W. M., Freimer, M. L., Cedarbaum, J. M., & Mendell, J. R. (2005) · Neurology · doi:10.1212/01.wnl.0000171978.70849.c5 · Cited by 197
TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons
Holtzman, D., Kilbridge, J., Li, Y., Cunningham, E., Lenn, N., Clary, D., Reichardt, L., & Mobley, W. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01567.1995 · Cited by 192
Gharami, K., Xie, Y., An, J. J., Tonegawa, S., & Xu, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05137.x · Cited by 184
BDNF overexpression increases dendrite complexity in hippocampal dentate gyrus
Tolwani, R. J., Buckmaster, P. S., Varma, S., Cosgaya, J. M., Wu, Y., Suri, C., & Shooter, E. M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00301-9 · Cited by 184
Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients
Laske, C., Stellos, K., Hoffmann, N., Stransky, E., Straten, G., Eschweiler, G. W., & Leyhe, T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001008 · Cited by 180
The Neurotrophins and Their Role in Alzheimers Disease
J. Allen, S., J. Watson, J., & Dawbarn, D. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376190 · Cited by 177
Kaplan, G. B., Vasterling, J. J., & Vedak, P. C. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833d8bc9 · Cited by 164
Suter, U., Heymach, J. V., & Shooter, E. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07778.x · Cited by 163
Chen, J., Chua, K., Chua, C. C., Yu, H., Pei, A., Chua, B. H. L., Hamdy, R. C., Xu, X., & Liu, C.-F. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.054 · Cited by 162
Jang, S.-W., Okada, M., Sayeed, I., Xiao, G., Stein, D., Jin, P., & Ye, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706662104 · Cited by 158
Eriksdotter-Jönhagen, M., Linderoth, B., Lind, G., Aladellie, L., Almkvist, O., Andreasen, N., Blennow, K., Bogdanovic, N., Jelic, V., Kadir, A., et al. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000336051 · Cited by 158
Neurotrophins and Psychiatric Disorders
Castrén, E. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_17 · Cited by 150
Arosio, B., Guerini, F. R., Voshaar, R. C. O., & Aprahamian, I. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.626906 · Cited by 145
Gärtner, A., Polnau, D. G., Staiger, V., Sciarretta, C., Minichiello, L., Thoenen, H., Bonhoeffer, T., & Korte, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3792-05.2006 · Cited by 137
Lazaridis, I., Charalampopoulos, I., Alexaki, V.-I., Avlonitis, N., Pediaditakis, I., Efstathopoulos, P., Calogeropoulou, T., Castanas, E., & Gravanis, A. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001051 · Cited by 128
Drosophila Neurotrophins Reveal a Common Mechanism for Nervous System Formation
Zhu, B., Pennack, J. A., McQuilton, P., Forero, M. G., Mizuguchi, K., Sutcliffe, B., Gu, C.-J., Fenton, J. C., & Hidalgo, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060284 · Cited by 126
BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease
Lim, Y. Y., Villemagne, V. L., Laws, S. M., Ames, D., Pietrzak, R. H., Ellis, K. A., Harrington, K. D., Bourgeat, P., Salvado, O., Darby, D., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.006 · Cited by 124
Lim, Y. Y., Villemagne, V. L., Laws, S. M., Pietrzak, R. H., Snyder, P. J., Ames, D., Ellis, K. A., Harrington, K., Rembach, A., Martins, R. N., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.123 · Cited by 123
Cunha, C., Angelucci, A., D'Antoni, A., Dobrossy, M. D., Dunnett, S. B., Berardi, N., & Brambilla, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.004 · Cited by 118
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception
Cappoli, N., Tabolacci, E., Aceto, P., & Russo, C. D. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577406 · Cited by 116
Wellmer, A., Misra, V. P., Sharief, M. K., Kopelman, P. G., & Anand, P. (2001) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2001.01019.x · Cited by 111
Lim, Y. Y., Villemagne, V. L., Laws, S. M., Ames, D., Pietrzak, R. H., Ellis, K. A., Harrington, K., Bourgeat, P., Bush, A. I., Martins, R. N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086498 · Cited by 110 · cited 2×
“…and adaptor proteins can lead to a cascade of downstream events involving calcium mobilization, and activation of several signaling proteins including extracellular regulated kinase (ERK) 1/2, protein kinase B (PKB, aka AKT), protein kinase C (PKC), and downstream transcription factors [63–65].”
BackgroundIncreased levels of NGF in sera of systemic lupus erythematosus patients
Bracci‐Laudiero, L., Aloe, L., Levi‐Montalcini, R., Galeazzi, M., Schilter, D., Scully, J. L., & Otten, U. (1993) · Neuroreport · doi:10.1097/00001756-199305000-00025 · Cited by 107
The Role of Neurotrophin Signaling in Age-Related Cognitive Decline and Cognitive Diseases
Numakawa, T., & Odaka, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147726 · Cited by 107
From modulator to mediator: rapid effects of BDNF on ion channels
Rose, C. R., Blum, R., Kafitz, K. W., Kovalchuk, Y., & Konnerth, A. (2004) · BioEssays · doi:10.1002/bies.20118 · Cited by 106
Expression of trk receptors in the developing and adult human central and peripheral nervous system
Muragaki, Y., Timothy, N., Leight, S., Hempstead, B. L., Chao, M. V., Trojanowski, J. Q., & Lee, V. M. ‐. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903560306 · Cited by 105
AAV1.NT-3 Gene Therapy for Charcot–Marie–Tooth Neuropathy
Sahenk, Z., Galloway, G., Clark, K. R., Malik, V., Rodino-Klapac, L. R., Kaspar, B. K., Chen, L., Braganza, C., Montgomery, C., & Mendell, J. R. (2014) · Molecular Therapy · doi:10.1038/mt.2013.250 · Cited by 103
Allosteric targeting of receptor tyrosine kinases
Smet, F. D., Christopoulos, A., & Carmeliet, P. (2014) · Nature Biotechnology · doi:10.1038/nbt.3028 · Cited by 101
Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice
Jang, S.-W., Liu, X., Chan, C. B., France, S. A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., Chang, Q., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011528 · Cited by 101
Mice lacking NT-3, and its receptor TrkC, exhibit profound deficiencies in CNS glial cells
Kahn, M. A., Kumar, S., Liebl, D., Chang, R., Parada, L. F., & De Vellis, J. (1999) · Glia · doi:10.1002/(sici)1098-1136(199904)26:2<153::aid-glia6>3.0.co;2-z · Cited by 98
Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists
Boltaev, U., Meyer, Y., Tolibzoda, F., Jacques, T., Gassaway, M., Xu, Q., Wagner, F., Zhang, Y.-L., Palmer, M., Holson, E., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal1670 · Cited by 94
A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease
Todd, D., Gowers, I., Dowler, S. J., Wall, M. D., McAllister, G., Fischer, D. F., Dijkstra, S., Fratantoni, S. A., van de Bospoort, R., Veenman-Koepke, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087923 · Cited by 93
Josephson, A., Widenfalk, J., Trifunovski, A., Widmer, H., Olson, L., & Spenger, C. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1380 · Cited by 89
Tolwani, R. J., Cosgaya, J. M., Varma, S., Jacob, R., Kuo, L. E., & Shooter, E. M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20181 · Cited by 89
Franzmeier, N., Ren, J., Damm, A., Monté-Rubio, G., Boada, M., Ruiz, A., Ramirez, A., Jessen, F., Düzel, E., Rodríguez Gómez, O., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0404-6 · Cited by 89
Nerve Growth Factor Regulates Gene Expression by Several Distinct Mechanisms
Cho, K.-O., Skarnes, W. C., Minsk, B., Palmieri, S. L., Jackson‐Grusby, L., & Wagner, J. A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.1.135 · Cited by 87
Mosiołek, A., Mosiołek, J., Jakima, S., Pięta, A., & Szulc, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153377 · Cited by 87
Formation and Evolution of the Chordate Neurotrophin and Trk Receptor Genes
Hallböök, F., Wilson, K., Thorndyke, M., & Olinski, R. P. (2006) · Brain, Behavior and Evolution · doi:10.1159/000094083 · Cited by 84
DiBenedetti, D. B., Slota, C., Wronski, S. L., Vradenburg, G., Comer, M., Callahan, L. F., Winfield, J., Rubino, I., Krasa, H. B., Hartry, A., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00659-6 · Cited by 80
BDNF val66met polymorphism affects aging of multiple types of memory
Kennedy, K. M., Reese, E. D., Horn, M. M., Sizemore, A. N., Unni, A. K., Meerbrey, M. E., Kalich, A. G., & Rodrigue, K. M. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.044 · Cited by 74
Shanks, H. R. C., Chen, K., Reiman, E. M., Blennow, K., Cummings, J. L., Massa, S. M., Longo, F. M., Börjesson‐Hanson, A., Windisch, M., & Schmitz, T. W. (2024) · Nature Medicine · doi:10.1038/s41591-024-02977-w · Cited by 74
Chiaretti, A., Conti, G., Falsini, B., Buonsenso, D., Crasti, M., Manni, L., Soligo, M., Fantacci, C., Genovese, O., Calcagni, M. L., et al. (2017) · Brain Injury · doi:10.1080/02699052.2017.1376760 · Cited by 73
In vivo functions of p75NTR: challenges and opportunities for an emerging therapeutic target
Malik, S. C., Sözmen, E. G., Baeza-Raja, B., Moan, N. L., Akassoglou, K., & Schachtrup, C. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.06.006 · Cited by 73
BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention
Boots, E. A., Schultz, S. A., Clark, L. R., Racine, A. M., Darst, B. F., Koscik, R. L., Carlsson, C. M., Gallagher, C. L., Hogan, K. J., Bendlin, B. B., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003980 · Cited by 70
Zhao, L., Lai, Y., Jiao, H., & Huang, J. (2024) · Nature Communications · doi:10.1038/s41467-024-47633-6 · Cited by 69
Mechanisms and regulation of neurotrophin synthesis and secretion
Alqudah, M., & Al‐Dwairi, A. (2016) · Neurosciences · doi:10.17712/nsj.2016.4.20160080 · Cited by 67
Neurotrophins Differentially Regulate Voltage-Gated Ion Channels
Lesser, S. S., Sherwood, N. T., & Lo, D. C. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1997.0656 · Cited by 63
Karami, A., Eyjolfsdottir, H., Vijayaraghavan, S., Lind, G., Almqvist, P., Kadir, A., Linderoth, B., Andreasen, N., Blennow, K., Wall, A., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.008 · Cited by 63
Vega, J. A., Vázquez, E., Naves, F. J., Soto, M. D. V., Calzada, B., & Represa, J. (1994) · The Anatomical Record · doi:10.1002/ar.1092400415 · Cited by 61
APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults
Ward, D. D., Summers, M. J., Saunders, N. L., Janssen, P., Stuart, K. E., & Vickers, J. C. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.022 · Cited by 60
Chiaretti, A., Antonelli, A., Genovese, O., Fernandez, E., Giuda, D., Mariotti, P., & Riccardi, R. (2008) · Neurological Research · doi:10.1179/016164107x247948 · Cited by 58
Dickson, S. P., Wessels, A. M., Dowsett, S. A., Mallinckrodt, C., Sparks, J. D., Chatterjee, S., & Hendrix, S. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.50 · Cited by 58
Bagal, S. K., Omoto, K., Blakemore, D. C., Bungay, P. J., Bilsland, J., Clarke, P. J., Corbett, M. S., Cronin, C. N., Cui, J. J., Dias, R., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00280 · Cited by 57
β-NGF and β-NGF receptor upregulation in blood and synovial fluid in osteoarthritis
Montagnoli, C., Tiribuzi, R., Crispoltoni, L., Pistilli, A., Stabile, A. M., Manfreda, F., Placella, G., Rende, M., & Cerulli, G. G. (2017) · Biological Chemistry · doi:10.1515/hsz-2016-0280 · Cited by 56
BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease
Białecka, M. A., Kurzawski, M., Roszmann, A., Robowski, P., Sitek, E. J., Honczarenko, K., Mak, M., Deptuła-Jarosz, M., Gołąb-Janowska, M., Droździk, M., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.051 · Cited by 54
Xue, B., Waseem, S. M. A., Zhu, Z., Alshahrani, M. A., Nazam, N., Anjum, F., Habib, A. H., Rafeeq, M. M., Nazam, F., & Sharma, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.925991 · Cited by 54
TrkA Tyrosine Residues Involved in NGF‐induced Neurite Outgrowth of PC12 Cells
Inagaki, N., Thoenen, H., & Lindholm, D. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01102.x · Cited by 53
Characterization of sensory deficits in TrkB knockout mice
Perez-Pinera, P., García-Suarez, O., Germanà, A., Díaz-Esnal, B., de Carlos, F., Silos-Santiago, I., del Valle, M. E., Cobo, J., & Vega, J. A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.035 · Cited by 52
Fletcher, J. L., Dill, L. K., Wood, R. J., Wang, S., Robertson, K., Murray, S. S., Zamani, A., & Semple, B. D. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113652 · Cited by 52
Baxter, R. M., Cohen, P., Obermeier, A., Ullrich, A., Downes, C. P., & Doza, Y. N. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.084_c.x · Cited by 51
BDNF-enriched small extracellular vesicles protect against noise-induced hearing loss in mice
Min, X., Deng, X., Lao, H., Wu, Z., Chen, Y., Luo, Y., Wu, H., Wang, J., Fu, Q., & Xiong, H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.007 · Cited by 51
Dhadda, S., Kanekiyo, M., Li, D. X., Swanson, C. J., Irizarry, M. C., Berry, S. M., Kramer, L. D., & Berry, D. A. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01129-x · Cited by 49
Eu, W. Z., Chen, Y., Chen, W., Wu, K., Tsai, C., Cheng, S., Carter, R. N., & Huang, G. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01280-3 · Cited by 48
Jain, P., Li, R., Lama, T., Saragovi, H. U., Cumberlidge, G., & Meerovitch, K. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.06.014 · Cited by 47
Yang, T., Massa, S. M., Tran, K. C., Simmons, D. A., Rajadas, J., Zeng, A. Y., Jang, T., Carsanaro, S., & Longo, F. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.015 · Cited by 46
Pediaditakis, I., Efstathopoulos, P., Prousis, K. C., Zervoú, M., Arévalo, J. C., Alexaki, V. I., Nikoletopoulou, V., Karagianni, E., Potamitis, C., Tavernarakis, N., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.007 · Cited by 46
McGregor, L. M., Baylin, S. B., Griffin, C. A., Hawkins, A. L., & Nelkin, B. D. (1994) · Genomics · doi:10.1006/geno.1994.1383 · Cited by 44
Molecular evolution of the neurotrophin family members and their Trk receptors
Lanave, C., Colangelo, A. M., Saccone, C., & Alberghina, L. (2007) · Gene · doi:10.1016/j.gene.2007.01.021 · Cited by 43
Swain, M., Soman, S. K., Tapia, K., Dagda, R. Y., & Dagda, R. K. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15945 · Cited by 43
Pankiewicz, P., Szybiński, M., Kisielewska, K., Gołębiowski, F., Krzemiński, P., Rutkowska-Włodarczyk, I., Moszczyński-Pętkowski, R., Gurba-Bryśkiewicz, L., Delis, M., Mulewski, K., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14080704 · Cited by 42 · cited 1×
“Both E2511 and ACD856 have been described as having no or very low agonistic effect on receptor function, but rather exert their action by modulating signaling [137,138,143,144].”
BackgroundAge-dependent deficits in fear learning in heterozygous BDNF knock-out mice
Endres, T., & Lessmann, V. (2012) · Learning & Memory · doi:10.1101/lm.028068.112 · Cited by 41
Chen, C., Ahn, E. H., Liu, X., Wang, Z.-H., Luo, S., Liao, J., & Ye, K. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00181 · Cited by 41
Holmes, S. E., Esterlis, I., Mazure, C. M., Lim, Y. Y., Ames, D., Rainey-Smith, S., Martins, R. N., Salvado, O., Dore, V., Villemagne, V. L., et al. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.08.007 · Cited by 40 · cited 1×
“…and adaptor proteins can lead to a cascade of downstream events involving calcium mobilization, and activation of several signaling proteins including extracellular regulated kinase (ERK) 1/2, protein kinase B (PKB, aka AKT), protein kinase C (PKC), and downstream transcription factors [63–65].”
BackgroundThe antidepressant-like effect of formononetin on chronic corticosterone-treated mice
Zhang, C., Zhu, L., Lu, S., Li, M., Bai, M., Li, Y., & Xu, E. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147844 · Cited by 40
Wang, Y., Li, O., Li, N., Sha, Z., Zhao, Z., & Xu, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1143833 · Cited by 38
Neurotrophin Regulation of Gene Expression
Bonni, A., & Greenberg, M. E. (1997) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032935 · Cited by 36
Pediaditakis, I., Kourgiantaki, A., Prousis, K. C., Potamitis, C., Xanthopoulos, K. P., Zervoú, M., Calogeropoulou, T., Charalampopoulos, I., & Gravanis, A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00512 · Cited by 36
Lim, Y. Y., Maruff, P. T., Barthélemy, N. R., Goate, A., Hassenstab, J. J., Sato, C., Fagan, A. M., Benzinger, T. L. S., Xiong, C., Cruchaga, C., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2021.5181 · Cited by 36
The juxtamembrane region of TrkA kinase is critical for inhibitor selectivity
Furuya, N., Momose, T., Katsuno, K., Fushimi, N., Muranaka, H., Handa, C., Ozawa, T., & Kinoshita, T. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.056 · Cited by 34
Dahlström, M., Madjid, N., Nordvall, G., Halldin, M. M., Vazquez-Juarez, E., Lindskog, M., Sandin, J., Winblad, B., Eriksdotter, M., & Forsell, P. (2021) · Cells · doi:10.3390/cells10081871 · Cited by 33 · cited 7×
“There was no effect on phospho-PLC γ , which counters the results obtained using primary neurons from wild-type mice where there was a large effect on phospho-Y785, suggesting an activation of the PLC γ pathway in wild-type neurons [138].”
BackgroundResultInfluentialSelf-citationZhang, Y., Wang, K., & Yu, Z. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01304 · Cited by 32
Gauthier, S. G., Aisen, P. S. S., Cummings, J. L., Detke, M. J., Longo, F. M., Raman, R., Sabbagh, M. N., Schneider, L. S., Tanzi, R. E., Tariot, P. N., et al. (2020) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2020.18 · Cited by 30
Gonzalez, S., McHugh, T. L. M., Yang, T., Syriani, W., Massa, S. M., Longo, F. M., & Simmons, D. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105563 · Cited by 30
Zagrebelsky, M., & Körte, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.374138 · Cited by 30
Adult trkB Signaling in Parvalbumin Interneurons is Essential to Prefrontal Network Dynamics
Guyon, N., Zacharias, L. R., van Lunteren, J. A., Immenschuh, J., Fuzik, J., Märtin, A., Xuan, Y., Zilberter, M. Y., Kim, H., Meletis, K., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1848-20.2021 · Cited by 28
TrkAIn VivoFunction Is Negatively Regulated by Ubiquitination
Kiris, E., Wang, T. Z., Yanpallewar, S. U., Dorsey, S. G., Becker, J., Bavari, S., Palko, M. E., Coppola, V., & Tessarollo, L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4294-13.2014 · Cited by 27
Structural and functional insights into lipid‐bound nerve growth factors
Tong, Q., Wang, F., Zhou, H., Sun, H., Song, H., Shu, Y., Gong, Y., Zhang, W., Cai, T., Yang, F., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-207316 · Cited by 26
Yang, C., Liang, R., Liu, Y., Meng, F., Zhou, F. H., Zhang, X., Ning, L., Wang, Z., Liu, S., & Zhou, X. (2023) · The FASEB Journal · doi:10.1096/fj.202301140rr · Cited by 24
Nakajima, S., Numakawa, T., Adachi, N., Ooshima, Y., Odaka, H., Yoshimura, A., & Kunugi, H. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.009 · Cited by 21
Biarc, J., Chalkley, R. J., Burlingame, A. L., & Bradshaw, R. A. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013375 · Cited by 21
New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye disease
Yu, Z., Joy, S., Mi, T., Yazdanpanah, G., Burgess, K., & de Paiva, C. S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.937142 · Cited by 21
Parrado‐Fernández, C., Juric, S., Backlund, M., Dahlström, M., Madjid, N., Lidell, V., Rasti, A., Sandin, J., Nordvall, G., & Forsell, P. K. A. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311159 · Cited by 21
Self-citationBiarc, J., Chalkley, R. J., Burlingame, A. L., & Bradshaw, R. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.475285 · Cited by 20
Madjid, N., Lidell, V., Nordvall, G., Lindskog, M., Ögren, S.-O., Forsell, P., & Sandin, J. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06410-x · Cited by 19
Self-citationStonnington, C. M., Velgos, S. N., Chen, Y., Syed, S., Huentelman, M. J., Thiyyagura, P., Lee, W., Richholt, R., Caselli, R. J., Locke, D. E. C., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200132 · Cited by 18
Charou, D., Rogdakis, T., Latorrata, A., Valcárcel, M., Papadogiannis, V., Athanasiou, C., Tsengenes, A., Papadopoulou, M. A., Lypitkas, D., Lavigne, M. D., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03818-w · Cited by 18
Han, D., Sun, D., Xiu, M., Su, X. R., Wang, J., Li, J., & Wang, D. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105392 · Cited by 17
Rogdakis, T., Charou, D., Latorrata, A., Papadimitriou, E., Tsengenes, A., Athanasiou, C., Papadopoulou, M. A., Chalikiopoulou, C., Κάτσιλα, Θ., Ramos, I., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030614 · Cited by 17
Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators
Jakaria, M., Belaidi, A. A., Southon, A. G., Dent, K. A., Lane, D. J. R., Bush, A. I., & Ayton, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416205 · Cited by 17
16th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA (USA) October 24–27, 2023: Symposia
(2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.129 · Cited by 17
Monshipouri, M., Jiang, H., & Lazarovici, P. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:14:1-2:069 · Cited by 16
Diniz, C. R. A. F., Crestani, A. P., Casarotto, P. C., Biojone, C., Cannarozzo, C., Winkel, F., Prozorov, M. A., Kot, E. F., Goncharuk, S. A., Marques, D. B., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.06.021 · Cited by 16
Latif‐Hernandez, A., Yang, T., Butler, R. R., Losada, P. M., Minhas, P. S., White, H., Tran, K. C., Liu, H., Simmons, D. A., Langness, V. F., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13857 · Cited by 14
Drosophila neurotrophins reveal a common mechanism for nervous system formation
Zhu, Z., Pennack, P., McQuilton, M., Forero, F., Mizuguchi, M., Sutcliffe, S., Gu, G., & Hidalgo, F. (2008) · SciVee · doi:10.4016/8389.01 · Cited by 11
Hsiang, H. W., Girard, B. M., Ratkovits, L., Campbell, S. E., & Vizzard, M. A. (2022) · Frontiers in Urology · doi:10.3389/fruro.2022.1037511 · Cited by 10
Önnestam, K., Nilsson, B., Rother, M., Rein-Hedin, E., Bylund, J., Anderer, P., Kemethofer, M., Halldin, M. M., Sandin, J., & Segerdahl, M. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.89 · Cited by 10
Self-citationNilsson, B., Bylund, J., Halldin, M. M., Rother, M., Rein‐Hedin, E., Önnestam, K., & Segerdahl, M. (2024) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-024-03645-1 · Cited by 9
Self-citationDAT1 and BDNF polymorphisms interact to predict Aβ and tau pathology
Ciampa, C. J., Morin, T., Murphy, A., Joie, R. L., Landau, S. M., & Berry, A. S. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.10.009 · Cited by 8
Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents
Antonijevic, M., Charou, D., Davis, A., Curel, T., Valcárcel, M., Ramos, I., Villacé, P., Claeysen, S., Dallemagne, P., Gravanis, A., et al. (2024) · Molecules · doi:10.3390/molecules29020515 · Cited by 8
Kargbo, R. B. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00506 · Cited by 7
Tomioka, T., Moriyama, Y., Hiramatsu, N., Kosasa, T., Kondo, K., & Wakita, H. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.051985 · Cited by 6
Review on allosteric modulators of dopamine receptors so far
Girmaw, F. (2024) · Health Science Reports · doi:10.1002/hsr2.1984 · Cited by 6
Narducci, D., Charou, D., Rogdakis, T., Zota, I., Bafiti, V., Zervoú, M., Κάτσιλα, Θ., Gravanis, A., Prousis, K. C., Charalampopoulos, I., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1244133 · Cited by 5
de Azeredo, L. A., Nardi, T. D., & Grassi‐Oliveira, R. (2017) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-3904 · Cited by 2
Tomioka, T., Hiramatsu, N., Moriyama, Y., & Kosasa, T. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.062590 · Cited by 2
Kernie, S. G., Liebl, D. J., & Parada, L. F. (1999) · Pediatric Research · doi:10.1203/00006450-199904020-00253 · Cited by 1
Aceves, P., Hall, N., Dayal, S., Yagi, T., Chang, J. Y., Mikamoto, M., Ringheim, G. E., Takesuya, T., Hiramatsu, N., Gordon, R., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.066208 · Cited by 1
Cited by
Small-Molecule Trk Agonists: Where Do We Go from Here?
Thompson, T. S., Sefiani, A., & Burgess, K. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02365 · Cited by 13
Designed NGF mimetics with reduced nociceptive signatures in neuronsPreprint
Schlichthaerle, T., Yang, A., Detraux, D., Johnson, D. E., Peach, C. J., Edman, N. I., Sniezek, C. M., Williams, C. A., Arora, S., Katiyar, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.14.648806 · Cited by 7
Turner-Ivey, B., Jenkins, D. P., & Carroll, S. L. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.03.012 · Cited by 4
Saleh, A. Y., Saputra, D. A. Y., Valentina, R., & Susanto, T. D. (2025) · F1000Research · doi:10.12688/f1000research.160416.3 · Cited by 4
Molecular determinants of signal transduction in tropomyosin receptor kinases
Enkavi, G. (2025) · FEBS Open Bio · doi:10.1002/2211-5463.70135 · Cited by 3
Metadata
- Authors
- Forsell, P., Parrado Fernández, C., Nilsson, B., Sandin, J., Nordvall, G., & Segerdahl, M.
- Affiliations
- Karolinska Institutet (SE)
- AlzeCure Pharma AB, Hälsovägen 7, 141 57 Huddinge, Sweden
- AlzeCure Pharma (Sweden) (SE)
- Corresponding author
- Forsell, Pontus
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2024-07-28
- Volume
- 17
- Issue
- 8
- Pages
- 997
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC11357672
- OpenAlex
- W4401209031
- Cited by
- 14
- References
- 184
- Citations by year
- 2026: 7 · 2025: 7
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- positive allosteric modulators, Trk receptors, Alzheimer's disease, neurotrophins, TrkA, disease-modifying therapy, symptomatic treatment, anti-amyloid monoclonal antibodies, cognitive enhancement, neurorestoration, neurodegenerative diseases, receptor tyrosine kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.